Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration 2024-09-14 19:43
Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024 2024-09-14 16:06
MediLink presents YL201 (B7H3 ADC) at ESMO 2024, with over 6-months PFS in SCLC, and showing pan-tumor benefits 2024-09-14 01:00
US FDA Grants RPD Designation to Senhwa Biosciences Silmitasertib for Pediatric Neuroblastoma 2024-09-13 13:49
Nona Biosciences Enters into Collaboration Agreement with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies 2024-09-13 09:27
Stapokibart Was Granted Marketing Approval From National Medical Products Administration For The Treatment Of Moderate-to-severe Atopic Dermatitis in Adults 2024-09-13 00:07
SECuRE trial advances: No dose limiting toxicities and strong preliminary efficacy data in first multi-dose cohort 2024-09-12 21:03
E-Home Household Services Holdings Limited's subsidiary Zhongrun Pharmaceutical and New Zealand's NBL Pharmaceuticals Sign Cooperation Agreement to Expand International Markets 2024-09-12 21:00
Bloomage 2024 Mid-Year Report: International Raw Materials Sales Surpass Domestic Chinese Market's for the First Time 2024-09-11 21:00
Collagen tripeptides: a new era of collagen drinks 2024-09-11 17:00
TCI Revolutionizes Weight Management with Breakthrough GLP-1 Innovation 2024-09-11 15:56
GC Cell and PT Bifarma Adiluhung sign a licensing agreement for Immuncell-LC to expand access in Indonesia 2024-09-11 09:48
Ractigen Announces Positive Clinical Data for RAG-17 in ALS-SOD1 Treatment from Investigator-Initiated Trial 2024-09-10 20:00
I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung Cancer 2024-09-10 19:00
The 2024 International (Bozhou) TCM Expo Kicked Off 2024-09-10 17:55
Bambusa Therapeutics Inc. Announces Successful Series Seed Funding to Advance Innovative Bispecific Antibodies for Immunology & Inflammation 2024-09-09 21:09
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization 2024-09-09 15:00
Senhwa Biosciences Presents Clinical Data Abstract on Pidnarulex at 2024 ESMO Congress 2024-09-09 10:33
Antennova to Present Latest Data of ATN-037 in a Mini Oral Presentation at ESMO Congress 2024 2024-09-09 08:30
Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation 2024-09-05 20:00
1 6 7 8 9 10 165